Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event Reporting.
Journal: JAMA ophthalmology
Published: December 04, 2025
Diagnostic Yield of Routine Metastatic Work-Up in Patients with Conjunctival Melanoma.
Journal: Seminars in ophthalmology
Published: February 21, 2025
Multicenter prospective validation study for international chronic ocular graft-versus-host disease consensus diagnostic criteria.
Journal: The ocular surface
Published: February 13, 2022
Mitigation and management strategies for ocular events associated with tisotumab vedotin.
Journal: Gynecologic oncology
Published: October 15, 2021
A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin.
Journal: Ophthalmic research
Published: October 14, 2021
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 12, 2021
A Review of Ocular Graft-versus-Host Disease: Pathophysiology, Clinical Presentation and Management.
A Review of Ocular Graft-versus-Host Disease: Pathophysiology, Clinical Presentation and Management.
Journal: Ocular immunology and inflammation
Published: July 06, 2021
Corneal Manifestations of Miltefosine Toxicity in Acanthamoeba Keratitis.
Journal: Ophthalmology
Published: May 18, 2021
Eltrombopag for Post-Transplantation Thrombocytopenia: Results of Phase II Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Transplantation and cellular therapy
Published: November 05, 2020
First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 28, 2020
Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 31, 2018
Phase I Trials of Anti-ENPP3 Antibody-Drug Conjugates in Advanced Refractory Renal Cell Carcinomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 08, 2018
Last Updated: 09/26/2026